MAPS | Tracking and Technology Supporting Monitoring of COVID-19

RELATED STORY: EVIDENCE (The Lancet) | Ventilator Survival Data — “What is the survival or death rate for COVID-19 patients who go on ventilators”? Read More …

Map of Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE

By Johns Hopkins CSSE
Confirmed Cases by Country/Region

SOURCE: Johns Hopkins CSSE;

Map of Cumulative Atypical Illness

By U.S. Health and Weather Map, By Kinsa Insights; Created in collaboration with Benjamin Dalziel, Oregon State University.

The Kinsa map (below) shows you how much influenza-like illness above the normal expected levels we have detected since March 1. The time series chart allows you to compare Kinsa’s observations of the influenza-like illness level in the U.S., in orange and red, against where we’d expect them to be, in blue, and see how that relationship has changed over the past few weeks


A company that makes internet-connected thermometers has followed the flu more closely than the C.D.C. can. Now the devices may be turning up cases of Covid-19.

Data is current as of: March 31, 2020

Update (3/27/2020): Our atypical Illness map now reflects the cumulative amount of atypical illnesses we’ve observed since March 1 — previously this map reflected only new atypical illness, updated daily. We think this way of looking at the data gives a more accurate and comprehensive view of what’s happening.

Update (3/24/2020): Due to widespread social distancing, school closures, stay-at-home orders, etc. feverish illness levels are dropping in many regions. This does not mean that COVID-19 cases are declining. In fact, we expect to see reported cases continue to surge in the near term, but it may indicate these measures are starting to slow the spread. See CDC COVID-19 Cases in U.S. for details.

View Kinsa Insights Map …


EVIDENCE | EBM PICO(T) Q: … “What Does The Medical Evidence and Literature Say About the Safety for Healthcare Professionals Using Cloth Fabric Materials as Protective Measures for Filtration and Protection from Common Particles and Viral Infections?”

CDC | Cases in U.S.

States Reporting Cases of COVID-19 to CDC*